271 related articles for article (PubMed ID: 36578580)
1. Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota.
Jiang H; Mao T; Sun Z; Shi L; Han X; Zhang Y; Zhang X; Wang J; Hu J; Zhang L; Li J; Han H
Front Microbiol; 2022; 13():1001778. PubMed ID: 36578580
[TBL] [Abstract][Full Text] [Related]
2. Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway.
Guo Y; Li JX; Wang YL; Mao TY; Chen C; Xie TH; Han YF; Tan X; Han HX
Evid Based Complement Alternat Med; 2017; 2017():6178358. PubMed ID: 28932253
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification.
Jiang H; Mao T; Liu Y; Tan X; Sun Z; Cheng Y; Han X; Zhang Y; Wang J; Shi L; Guo Y; Li J; Han H
Front Pharmacol; 2022; 13():908128. PubMed ID: 35721171
[TBL] [Abstract][Full Text] [Related]
4. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
[TBL] [Abstract][Full Text] [Related]
5. Zanthoxylum bungeanum amides ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK/Nrf2 signaling.
Peng W; He CX; Li RL; Qian D; Wang LY; Chen WW; Zhang Q; Wu CJ
J Ethnopharmacol; 2024 Jan; 318(Pt A):116848. PubMed ID: 37423515
[TBL] [Abstract][Full Text] [Related]
6. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
[TBL] [Abstract][Full Text] [Related]
7. Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism.
Cui H; Li Y; Wang Y; Jin L; Yang L; Wang L; Liao J; Wang H; Peng Y; Zhang Z; Wang H; Liu X
Front Pharmacol; 2020; 11():584090. PubMed ID: 33328987
[TBL] [Abstract][Full Text] [Related]
8. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
9. Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction.
Yu S; Qian H; Tian D; Yang M; Li D; Xu H; Chen J; Yang J; Hao X; Liu Z; Zhong J; Yang H; Chen X; Min X; Chen J
Front Pharmacol; 2023; 14():1074837. PubMed ID: 37089931
[No Abstract] [Full Text] [Related]
10. Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids.
Ni Y; Wang X; Wu Q; Yao Y; Xu Y; Li Y; Feng Q; Zhou M; Gou X
Front Endocrinol (Lausanne); 2023; 14():1272214. PubMed ID: 37900123
[TBL] [Abstract][Full Text] [Related]
11. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
12. Er-Chen Decoction Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Rats through Remodeling Gut Microbiota and Regulating the Serum Metabolism.
Miao J; Guo L; Cui H; Wang L; Zhu B; Lei J; Li P; Jia J; Zhang Z
Evid Based Complement Alternat Med; 2022; 2022():6221340. PubMed ID: 35399623
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.
Liu H; Xu J; Li H; Zhang L; Xu P
Anat Rec (Hoboken); 2021 Nov; 304(11):2605-2619. PubMed ID: 34536264
[TBL] [Abstract][Full Text] [Related]
14. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
[TBL] [Abstract][Full Text] [Related]
15. Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD.
Li J; Hu Q; Xiao-Yu D; Zhu L; Miao YF; Kang HX; Zhao XL; Yao JQ; Long D; Tang WF; Wan MH
Evid Based Complement Alternat Med; 2020; 2020():6697638. PubMed ID: 33293992
[TBL] [Abstract][Full Text] [Related]
16. Linggui Zhugan decoction delays ventricular remodeling in rats with chronic heart failure after myocardial infarction through the Wnt/β-catenin signaling pathway.
Yang M; Wu H; Qian H; Li D; Xu H; Chen J; Zhong J; Wu W; Yang H; Chen X; Min X; Chen J
Phytomedicine; 2023 Nov; 120():155026. PubMed ID: 37619320
[TBL] [Abstract][Full Text] [Related]
17. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
[TBL] [Abstract][Full Text] [Related]
18. Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota.
Liao J; Xie X; Gao J; Zhang Z; Qu F; Cui H; Cao Y; Han X; Zhao J; Wen W; Wang H
Evid Based Complement Alternat Med; 2021; 2021():5522755. PubMed ID: 33824675
[TBL] [Abstract][Full Text] [Related]
19. Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet.
Bi CR; Sun JT; Du J; Chu LY; Li YJ; Jia XY; Liu Y; Zhang WP; Li YC; Liu YJ
Front Cell Infect Microbiol; 2022; 12():1005318. PubMed ID: 36683694
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease.
Yu JS; Youn GS; Choi J; Kim CH; Kim BY; Yang SJ; Lee JH; Park TS; Kim BK; Kim YB; Roh SW; Min BH; Park HJ; Yoon SJ; Lee NY; Choi YR; Kim HS; Gupta H; Sung H; Han SH; Suk KT; Lee DY
Clin Transl Med; 2021 Dec; 11(12):e634. PubMed ID: 34965016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
